Details for 2020729951

Up to date per 05.04.2026

Actions

Title / Product Name

DOSIERSCHEMA FÜR ANTI-BCMA-WIRKSTOFFE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020729951

EP Publication Number

4058148

E-Number

1665206

Language

PCT Number

EP20062876

Publication Date

21.09.2022 A

13.03.2024 B1

Registration Date

13.03.2024

AT Publication Date

15.04.2024

Application Date

08.05.2020

Registration Number

Priorities

11.11.2019

19208417

IPC

A61P 35/00 20060101AFI20210521BHEP

Maximum Duration of Protection

08.05.2040

Owner

Amgen Research (Munich) GmbHStaffelseestrasse 2 81477 MünchenDE

Amgen Inc.One Amgen Center Drive Thousand Oaks, California 91320-1799US

Representative

No representatives present

Inventor

STIEGLMAIER, Juliac/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MuenchenDE

HUBER, Birgitc/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MuenchenDE

MINELLA, Alexanderc/o Amgen Inc. One Amgen Center Drive Thousand Oaks, California 91320US

UPRETI, Vijayc/o Amgen Inc. One Amgen Center Drive Thousand Oaks, California 91320US

Information about Fees